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Britain is pressing ahead with stem cell research as the Prime 
Minister, Tony Blair, told the receptive Californian governor, Arnold 
Schwarzenegger, last month. Nigel Williams reports.
UK pushes stem cell supportBritain is backing stem cell 
research with new international 
links and domestic projects 
within an EU still willing to fund 
certain types of research. And the 
British Prime Minister, Tony Blair, 
used his trip to California last 
month to back the field in spite of 
sharp opposition from President 
George Bush, who used his first 
presidential veto to block federal 
funding for human embryonic stem 
cell research just days earlier.
Blair met with the state 
governor, Arnold Schwarzenegger. 
who also backs stem cell 
research, along with staff from 
10 bioscience companies based in the San Francisco area, and 
unveiled plans for a joint UK–
California conference on stem cell 
technology in Britain in November. 
California has pledged state 
funds in an initiative supported by 
voters, although this is presently 
under challenge in the courts.
While Blair was in the US, 
Britain’s Wellcome Trust 
announced funding of £10 million 
to establish an international centre 
of excellence in fundamental 
stem cell research at the 
University of Cambridge, due to 
open in December. The Medical 
Research Council and the Wolfson 
Foundation are also contributing £1.5 million each towards the 
centre.
Austin Smith, former director 
of the Centre for Stem Cell 
Research at Edinburgh University, 
will become director of the new 
Wellcome Trust Centre for Stem 
Cell Research in Cambridge. 
“Stem cell biology is a young and 
complex area of basic research 
with emerging potential for 
biomedical applications,” he says. 
“Historically the United Kingdom 
has been a world leader in stem 
cell research. There is now a 
crucial opportunity to extend this 
due to the current restrictions 
on public funding of human 
embryonic stem cell research in 
the United States.”
And Britain is now backing new 
means to provide fresh human Common ground: George Bush may have blocked federal funding for human embryonic stem cell research but Tony Blair and Arnold 
Schwarzenegger announced a future joint UK–California meeting on the subject last month. (Photo: Stefan Rousseau/PA/EMPICS.)
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Photo Library.)eggs for cloning and stem cell 
work. As a result of a new ruling, 
women undergoing in vitro 
fertilisation (IVF) treatment will 
be able to halve the cost of the 
expensive procedure under the 
new ruling which allows them to 
sell some of their eggs for use 
in stem cell research. Scientists 
at Newcastle University, who 
created the world’s first cloned 
human embryo last year, were 
last month granted a licence for 
‘egg sharing’ by the Human 
Fertilisation and Embryology 
Authority.
Egg-sharing has been 
in operation at IVF centres 
for 10 years, but scientists 
from Newcastle and Durham 
universities are the first to be 
granted permission to extend the 
system so that it provides eggs 
for research. The new scheme 
involves the research team, from 
the North East England Stem 
Cell Institute (NESCI), paying half 
the cost of an egg donor’s IVF 
treatment in return for a donation 
of up to half the eggs produced 
for research.
Until now, researchers 
investigating stem cells and 
therapeutic cloning have generally 
had to make do with surplus 
unfertilised eggs from IVF clinics. 
But this generates only a highly 
restricted supply of poor-quality eggs. For the best chance of 
success, scientists know they 
must have a good source of fresh 
eggs, rather than ‘failed’ clinic 
rejects.
It is hoped that donors will 
be recruited at the rate of one a 
week. Each is expected to provide 
the researchers with between 
six and ten fresh eggs. The team 
believes the scheme, which still 
needs to be funded and is not 
expected to come into operation 
until next year, will speed up 
progress towards developing 
stem cell treatments.
Alison Murdoch, whose team 
at NESCI has been granted the 
licence, said that paying women 
would not make any difference 
to their treatment. “It won’t put 
the women at any increased risk 
because they are going to have 
exactly the same treatment that 
they are going to have for IVF 
anyway,” she said, adding that 
it would enable more women to 
afford treatment.
But critics worry that the dual 
purpose of the treatment will 
create a potential conflict of 
interest for doctors. For example, 
donors might be given an 
inappropriately high dose of drugs 
used to stimulate the ovary so 
that more eggs can be extracted. 
“It’s pulling the clinicians in two 
different ways,” says Donna Dickenson, at Birkbeck College, 
London, who sits on the ethics 
committee of the Royal College of 
Obstetricians and Gynaecologists. 
“The primary objective has got to 
be to treat the individual patient, 
but if there is also a desire to 
harvest extra [eggs]… I think 
there could be two conflicting 
objectives,” she said.
Last year, Murdoch’s team was 
granted approval by the HFEA 
to ask IVF patients to donate, 
without payment, two eggs to 
research if more than 12 eggs 
had been collected for their 
treatment. But in seven months 
they were able to collect only 
66 eggs, which were available 
unpredictably.
The HFEA also unveiled a 
public consultation on egg 
donation for research by women 
not undergoing IVF. This is more 
controversial, because it involves 
the donor taking hormonal drugs 
which stop the menstrual cycle 
and then over-stimulate the ovary 
to release more eggs than usual.
Such donations are currently 
only permitted to women 
undergoing fertility treatment. 
Dickenson said there were risks 
to donors from hormonal drugs, 
and the longer term risks were 
not yet known.
The new moves in stem cell 
research in Britain came as an 
EU council meeting agreed last 
month that research should 
still be funded on the use of 
human embryonic stem cells 
as long as it did not involve the 
destruction of embryos for the 
harvesting of stem cell lines. 
The decision follows intense 
lobbying from some groups to 
stop the EU’s funding for stem 
cell research altogether. The 
Vatican is vociferously opposed 
to research involving stem cells 
and its newspaper, L’Osservatore 
Romano, termed the agreement 
‘the macabre product of a twisted 
sense of progress’.
But the British science minister, 
Lord Sainsbury, welcomed the 
decision. “In Europe we are 
moving forward on this front, 
whereas America has taken, as 
far as the federal government 
is concerned, a very negative 
position. That Europe is moving 
forward is extremely good.”
